Histone methyltransferase SETD1A participates in lung cancer progression

Lung cancer is the leading cause of cancer‐related death worldwide, with an estimated 1.2 million deaths each year. Despite advances in lung cancer treatment, 5‐year survival rates are lower than ~15%, which is attributes to diagnosis limitations and current clinical drug resistance. Recently, more...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Mei, Gong, Piping, Zhang, Yun, Liu, Yanguo, Liu, Xiaozhen, Zhang, Feng, Wang, Xiuwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365002/
https://www.ncbi.nlm.nih.gov/pubmed/34219384
http://dx.doi.org/10.1111/1759-7714.14065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365002/
https://www.ncbi.nlm.nih.gov/pubmed/34219384
http://dx.doi.org/10.1111/1759-7714.14065

Ejemplares similares